Cargando…

Communicating about COVID-19 vaccine development and safety

PURPOSE: Beliefs that the risks from a COVID-19 vaccine outweigh the risks from getting COVID-19 and concerns that the vaccine development process was rushed and lacking rigor have been identified as important drivers of hesitancy and refusal to get a COVID-19 vaccine. We tested whether messages des...

Descripción completa

Detalles Bibliográficos
Autores principales: Thorpe, Alistair, Fagerlin, Angela, Butler, Jorie, Stevens, Vanessa, Drews, Frank A., Shoemaker, Holly, Riddoch, Marian S., Scherer, Laura D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355181/
https://www.ncbi.nlm.nih.gov/pubmed/35930557
http://dx.doi.org/10.1371/journal.pone.0272426
_version_ 1784763235132506112
author Thorpe, Alistair
Fagerlin, Angela
Butler, Jorie
Stevens, Vanessa
Drews, Frank A.
Shoemaker, Holly
Riddoch, Marian S.
Scherer, Laura D.
author_facet Thorpe, Alistair
Fagerlin, Angela
Butler, Jorie
Stevens, Vanessa
Drews, Frank A.
Shoemaker, Holly
Riddoch, Marian S.
Scherer, Laura D.
author_sort Thorpe, Alistair
collection PubMed
description PURPOSE: Beliefs that the risks from a COVID-19 vaccine outweigh the risks from getting COVID-19 and concerns that the vaccine development process was rushed and lacking rigor have been identified as important drivers of hesitancy and refusal to get a COVID-19 vaccine. We tested whether messages designed to address these beliefs and concerns might promote intentions to get a COVID-19 vaccine. METHOD: We conducted an online survey fielded between March 8–23, 2021 with US Veteran (n = 688) and non-Veteran (n = 387) respondents. In a between-subjects experiment, respondents were randomly assigned to a control group (with no message) or to read one of two intervention messages: 1. a fact-box styled message comparing the risks of getting COVID-19 compared to the vaccine, and 2. a timeline styled message describing the development process of the COVID-19 mRNA vaccines. RESULTS: Most respondents (60%) wanted a COVID-19 vaccine. However, 17% expressed hesitancy and 23% did not want to get a COVID-19 vaccine. The fact-box styled message and the timeline message did not significantly improve vaccination intentions, F(2,358) = 0.86, p = .425, [Image: see text] = .005, or reduce the time respondents wanted to wait before getting vaccinated, F(2,306) = 0.79, p = .453, [Image: see text] = .005, compared to no messages. DISCUSSION: In this experimental study, we did not find that providing messages about vaccine risks and the development process had an impact on respondents’ vaccine intentions. Further research is needed to identify how to effectively address concerns about the risks associated with COVID-19 vaccines and the development process and to understand additional factors that influence vaccine intentions.
format Online
Article
Text
id pubmed-9355181
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-93551812022-08-06 Communicating about COVID-19 vaccine development and safety Thorpe, Alistair Fagerlin, Angela Butler, Jorie Stevens, Vanessa Drews, Frank A. Shoemaker, Holly Riddoch, Marian S. Scherer, Laura D. PLoS One Research Article PURPOSE: Beliefs that the risks from a COVID-19 vaccine outweigh the risks from getting COVID-19 and concerns that the vaccine development process was rushed and lacking rigor have been identified as important drivers of hesitancy and refusal to get a COVID-19 vaccine. We tested whether messages designed to address these beliefs and concerns might promote intentions to get a COVID-19 vaccine. METHOD: We conducted an online survey fielded between March 8–23, 2021 with US Veteran (n = 688) and non-Veteran (n = 387) respondents. In a between-subjects experiment, respondents were randomly assigned to a control group (with no message) or to read one of two intervention messages: 1. a fact-box styled message comparing the risks of getting COVID-19 compared to the vaccine, and 2. a timeline styled message describing the development process of the COVID-19 mRNA vaccines. RESULTS: Most respondents (60%) wanted a COVID-19 vaccine. However, 17% expressed hesitancy and 23% did not want to get a COVID-19 vaccine. The fact-box styled message and the timeline message did not significantly improve vaccination intentions, F(2,358) = 0.86, p = .425, [Image: see text] = .005, or reduce the time respondents wanted to wait before getting vaccinated, F(2,306) = 0.79, p = .453, [Image: see text] = .005, compared to no messages. DISCUSSION: In this experimental study, we did not find that providing messages about vaccine risks and the development process had an impact on respondents’ vaccine intentions. Further research is needed to identify how to effectively address concerns about the risks associated with COVID-19 vaccines and the development process and to understand additional factors that influence vaccine intentions. Public Library of Science 2022-08-05 /pmc/articles/PMC9355181/ /pubmed/35930557 http://dx.doi.org/10.1371/journal.pone.0272426 Text en https://creativecommons.org/publicdomain/zero/1.0/This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication.
spellingShingle Research Article
Thorpe, Alistair
Fagerlin, Angela
Butler, Jorie
Stevens, Vanessa
Drews, Frank A.
Shoemaker, Holly
Riddoch, Marian S.
Scherer, Laura D.
Communicating about COVID-19 vaccine development and safety
title Communicating about COVID-19 vaccine development and safety
title_full Communicating about COVID-19 vaccine development and safety
title_fullStr Communicating about COVID-19 vaccine development and safety
title_full_unstemmed Communicating about COVID-19 vaccine development and safety
title_short Communicating about COVID-19 vaccine development and safety
title_sort communicating about covid-19 vaccine development and safety
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355181/
https://www.ncbi.nlm.nih.gov/pubmed/35930557
http://dx.doi.org/10.1371/journal.pone.0272426
work_keys_str_mv AT thorpealistair communicatingaboutcovid19vaccinedevelopmentandsafety
AT fagerlinangela communicatingaboutcovid19vaccinedevelopmentandsafety
AT butlerjorie communicatingaboutcovid19vaccinedevelopmentandsafety
AT stevensvanessa communicatingaboutcovid19vaccinedevelopmentandsafety
AT drewsfranka communicatingaboutcovid19vaccinedevelopmentandsafety
AT shoemakerholly communicatingaboutcovid19vaccinedevelopmentandsafety
AT riddochmarians communicatingaboutcovid19vaccinedevelopmentandsafety
AT schererlaurad communicatingaboutcovid19vaccinedevelopmentandsafety